title: Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
abstract: The catecholamine, dopamine (DA), is synthesized from 3,4-dihydroxy-L-phenylalanine (L-DOPA) by aromatic L-amino acid decarboxylase (AADC). Dopamine metabolism is regulated by monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT). To measure dopaminergic metabolism, we used microdialysis with radiometric detection to monitor L-[β-(11)C]DOPA metabolites in the extracellular space of the rat striatum. We also evaluated the effects of AADC, MAO, and COMT inhibitors on metabolite profiles. The major early species measured after administration of L-[β-(11)C]DOPA were [(11)C]3,4-dihydroxyphenylacetic acid ([(11)C]DOPAC) and [(11)C]homovanillic acid ([(11)C]HVA) in a 1:1 ratio, which shifted toward [(11)C]HVA with time. An AADC inhibitor increased the uptake of L-[β-(11)C]DOPA and L-3-O-methyl-[(11)C]DOPA and delayed the accumulation of [(11)C]DOPAC and [(11)C]HVA. The MAO and COMT inhibitors increased the production of [(11)C]3-methoxytyramine and [(11)C]DOPAC, respectively. These results reflect the L-DOPA metabolic pathway, suggesting that this method may be useful for assessing dopaminergic metabolism.
authors.affiliation: Molecular Probe Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan. mokada@nirs.go.jp
authors.forename: Maki
authors.initials: M
authors.lastname: Okada
authors.forename: Ryuji
authors.initials: R
authors.lastname: Nakao
authors.forename: Rie
authors.initials: R
authors.lastname: Hosoi
authors.forename: Ming-Rong
authors.initials: MR
authors.lastname: Zhang
authors.forename: Toshimitsu
authors.initials: T
authors.lastname: Fukumura
authors.forename: Kazutoshi
authors.initials: K
authors.lastname: Suzuki
authors.forename: Osamu
authors.initials: O
authors.lastname: Inoue
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001545:Benserazide / Q000494:pharmacology; D001711:Biotransformation; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D004298:Dopamine / Q000378:metabolism*; D015259:Dopamine Agents / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D045604:Extracellular Fluid / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D007980:Levodopa; D008297:Male; D017551:Microdialysis; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D017072:Neostriatum / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D010293:Pargyline / Q000494:pharmacology; D019275:Radiopharmaceuticals; D051381:Rats; D017207:Rats, Sprague-Dawley; D013056:Spectrophotometry, Ultraviolet
chemical_list: D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols; D015259:Dopamine Agents; D004791:Enzyme Inhibitors; D008996:Monoamine Oxidase Inhibitors; D019275:Radiopharmaceuticals; D015102:3,4-Dihydroxyphenylacetic Acid; D007980:Levodopa; D001545:Benserazide; D010293:Pargyline; C057726:OR486; D004298:Dopamine; D006719:Homovanillic Acid
references.citation: CNS Drug Rev. 2007 Fall;13(3):352-79
references.pmid: 17894650
references.citation: Synapse. 1997 Dec;27(4):294-302
references.pmid: 9372552
references.citation: J Neural Transm Gen Sect. 1994;95(1):1-15
references.pmid: 7857582
references.citation: Brain Res. 1992 Apr 24;578(1-2):122-8
references.pmid: 1511268
references.citation: Neurosci Lett. 1991 Oct 28;132(1):19-22
references.pmid: 1787913
references.citation: Proc R Soc Med. 1969 Nov;62(11 Part 1):1099-101
references.pmid: 5356862
references.citation: Neuropsychopharmacology. 2006 Jan;31(1):139-50
references.pmid: 15956989
references.citation: Pharmacotherapy. 2007 Dec;27(12 Pt 2):174S-185S
references.pmid: 18041937
references.citation: Pharmacol Res. 1997 Apr;35(4):313-5
references.pmid: 9264047
references.citation: Parkinsonism Relat Disord. 2003 Jan;9(3):145-50
references.pmid: 12573869
references.citation: Brain Res. 2000 Sep 15;877(1):31-6
references.pmid: 10980240
references.citation: Clin Chem. 2003 Oct;49(10):1763-73
references.pmid: 14500617
references.citation: Ann N Y Acad Sci. 2004 Jun;1018:224-30
references.pmid: 15240373
references.citation: J Neurosci Methods. 2009 Oct 30;184(1):37-41
references.pmid: 19619585
references.citation: Synapse. 1997 Dec;27(4):336-46
references.pmid: 9372556
references.citation: J Neurochem. 1996 Mar;66(3):1113-7
references.pmid: 8769873
references.citation: Neurochem Res. 2008 Mar;33(3):401-11
references.pmid: 17713853
references.citation: Br J Anaesth. 2005 Oct;95(4):485-94
references.pmid: 16113039
references.citation: J Neurosci. 1998 Aug 1;18(15):5901-7
references.pmid: 9671677
references.citation: Anal Chem. 2006 Mar 15;78(6):1755-60
references.pmid: 16536408
references.citation: Anal Chem. 2006 Oct 1;78(19):6717-25
references.pmid: 17007489
references.citation: J Neural Transm (Vienna). 2001;108(5):559-70
references.pmid: 11459076
references.citation: Br J Clin Pharmacol. 1986 Oct;22(4):429-36
references.pmid: 3533125
references.citation: J Pharm Biomed Anal. 1995 Apr;13(4-5):361-7
references.pmid: 9696544
references.citation: Nucl Med Commun. 2006 Sep;27(9):723-31
references.pmid: 16894327
references.citation: J Neural Transm (Vienna). 2004 Oct;111(10-11):1343-63
references.pmid: 15340869
references.citation: Biol Psychiatry. 1999 Sep 1;46(5):681-8
references.pmid: 10472420
references.citation: Synapse. 1998 May;29(1):37-61
references.pmid: 9552174
references.citation: Br J Pharmacol. 1997 Jul;121(6):1171-9
references.pmid: 9249254
references.citation: Pharmacol Rev. 2004 Sep;56(3):331-49
references.pmid: 15317907
references.citation: Adv Neurol. 1987;45:19-34
references.pmid: 2881444
references.citation: Neuroscience. 2003;120(2):425-33
references.pmid: 12890512
references.citation: Expert Opin Drug Deliv. 2009 Apr;6(4):389-404
references.pmid: 19382882
references.citation: Appl Radiat Isot. 2000 Feb;52(2):199-204
references.pmid: 10697728
references.citation: Synapse. 1998 Dec;30(4):351-61
references.pmid: 9826227
references.citation: J Chromatogr A. 2008 Sep 5;1203(2):193-7
references.pmid: 18674768
references.citation: J Cereb Blood Flow Metab. 1996 Sep;16(5):854-63
references.pmid: 8784230